First Trust Direct Indexing’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,059
| Closed | -$2.58M | – | 86 |
|
|
2024
Q3 | $2.58M | Buy |
33,059
+1,246
| +4% | +$97.1K | 0.14% | 147 |
|
|
2024
Q2 | $2.48M | Buy |
31,813
+2,864
| +10% | +$223K | 0.15% | 121 |
|
|
2024
Q1 | $1.96M | Buy |
28,949
+798
| +3% | +$54.1K | 0.15% | 146 |
|
|
2023
Q4 | $1.9M | Sell |
28,151
-388
| -1% | -$26.1K | 0.17% | 130 |
|
|
2023
Q3 | $1.93M | Sell |
28,539
-7,803
| -21% | -$528K | 0.22% | 101 |
|
|
2023
Q2 | $2.6M | Sell |
36,342
-165
| -0.5% | -$11.8K | 0.29% | 58 |
|
|
2023
Q1 | $2.53M | Buy |
36,507
+2,635
| +8% | +$183K | 0.3% | 63 |
|
|
2022
Q4 | $2.3M | Sell |
33,872
-1,805
| -5% | -$122K | 0.3% | 70 |
|
|
2022
Q3 | $1.96M | Buy |
35,677
+1,046
| +3% | +$57.4K | 0.29% | 68 |
|
|
2022
Q2 | $2.29M | Buy |
34,631
+7,600
| +28% | +$502K | 0.32% | 59 |
|
|
2022
Q1 | $1.79M | Sell |
27,031
-5,361
| -17% | -$356K | 0.22% | 92 |
|
|
2021
Q4 | $1.89M | Buy |
32,392
+709
| +2% | +$41.3K | 0.24% | 82 |
|
|
2021
Q3 | $1.9M | Buy |
31,683
+14,218
| +81% | +$854K | 0.27% | 77 |
|
|
2021
Q2 | $1.05M | Buy |
17,465
+8,886
| +104% | +$532K | 0.16% | 165 |
|
|
2021
Q1 | $427K | Buy |
8,579
+223
| +3% | +$11.1K | 0.11% | 247 |
|
|
2020
Q4 | $418K | Buy |
+8,356
| New | +$418K | 0.11% | 224 |
|